by The U.S. digital therapeutics market size accounted for US$ 2.05 Bn in 2022 and is projected to reach around USD 12.09 Bn by 2030, growing at a CAGR of 24.85% from 2022 to 2030.
Report Summary
The global U.S. digital therapeutics market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the U.S. digital therapeutics market across the globe.
A comprehensive estimate on the U.S. digital therapeutics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of U.S. digital therapeutics during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2410
U.S. Digital Therapeutics Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 2.05 Billion |
| Market Size by 2030 | USD 12.09 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 24.85% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized U.S. digital therapeutics market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Enterprise Artificial Intelligence Market Size To Cross USD 102.9 Bn By 2030
Market Players
The report includes the profiles of key U.S. digital therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Omada Health Inc.
- 2Morrow Inc.
- Teladoc Health, Inc
- Pear Therapeutics (U.S), Inc.
- Fitbit Health Solutions
- Welldoc, Inc
- Click Therapeutics
- Noom, Inc.
- Akili, Inc.
- Better Therapeutics, Inc
U.S. Digital Therapeutics Market Segmentation
By Application
- Diabetes
- Obesity
- Central Nervous System Diseases
- Cardiovascular Disease (CVD)
- Respiratory Disease
- Smoking Cessation
- Gastrointestinal Disorder (GID)
- Others
By Product
- Software
- Device
By End Use
- Patients
- Providers
- Payers
- Employers
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Digital Therapeutics Market
5.1. COVID-19 Landscape: U.S. Digital Therapeutics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global U.S. Digital Therapeutics Market, By Application
8.1. U.S. Digital Therapeutics Market, by Application, 2022-2030
8.1.1 Diabetes
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Obesity
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Central Nervous System Diseases
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Cardiovascular Disease (CVD)
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Respiratory Disease
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Smoking Cessation
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Gastrointestinal Disorder (GID)
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global U.S. Digital Therapeutics Market, By Product
9.1. U.S. Digital Therapeutics Market, by Product, 2022-2030
9.1.1. Software
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Device
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global U.S. Digital Therapeutics Market, By End Use
10.1. U.S. Digital Therapeutics Market, by End Use, 2022-2030
10.1.1. Patients
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Providers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Payers
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Employers
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global U.S. Digital Therapeutics Market, Regional Estimates and Trend Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Application (2017-2030)
11.1.2. Market Revenue and Forecast, by Product (2017-2030)
11.1.3. Market Revenue and Forecast, by End Use (2017-2030)
Chapter 12. Company Profiles
12.1. Omada Health Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. 2Morrow Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Teladoc Health, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Pear Therapeutics (U.S), Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Fitbit Health Solutions
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Welldoc, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Click Therapeutics
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Noom, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Akili, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Better Therapeutics, Inc
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
